A 16-year-old girl from Jiangsu Province, China, complained of crusted verrucous skin lesions over her left ear and left buttock. The patient had received a cosmetic piercing in her left ear lobule, which was done following routine procedures and was unremarkable. Two months later, several 3 ϫ 3 mm papules with exudates appeared sporadically around the piercing area on the left ear and gradually became crusted verrucous lesions which spread to almost the entire preauricular areas of the ear (Fig. 1a) . Over the subsequent 5 months, an infection developed on the left buttock with similar lesions (Fig. 1b) We present the third case of phaeohyphomycosis caused by Veronaea botryosa in China and the tenth case worldwide. A 16-year-old Chinese girl developed crusted, verrucous lesions, initially on the left ear and later on the left buttock, within 2 -5 months of receiving an ear piercing. Histopathological examination of biopsy specimens confi rmed diagnosis of subcutaneous phaeohyphomycosis. Microscopic examination of the colonies recovered in culture from a portion of the biopsy specimen resulted in the identifi cation of Veronaea botryosa based primarily on the presence of two-celled, brownish pigmented, cylindrical conidia produced sympodially from erect conidiogenous cells. The lesions signifi cantly improved with daily oral treatment with itraconazole 400 mg and adjuvant thermotherapy for 6 months. A maintenance therapy with low dose itraconazole was prescribed in order to achieve clinical and mycological cure. A two-year follow-up didn ' t reveal any recurrence of infection. Our case is the fi rst report of V. botryosa infection associated with a cosmetic procedure, which suggests that skin piercing could precipitate V. botryosa or other dematiaceous, as well as opportunistic fungal infections.
Introduction
Phaeohyphomycotic infections, caused by a diverse group of melanized fungi, are being increasingly reported worldwide. Melanized fungi are commonly found as saprophytes in soil, on plants and in water and are characterized by the production of dark melanin pigment in the mycelium and conidia. There are only ten reported cases of phaeohyphomycotic infections caused by Veronaea botryose , primarily from Asia. In this report we present the third case of subcutaneous phaeohyphomycosis due to V. botryosa in China, as well as a brief review of literature on V. botryosa local dermatologist and had been treated with topical steroids and antifungals, which did not result in improvement of the lesions. The latter had gradually enlarged and become 5 ϫ 5-mm nodules, which in 50% of the ear had coalesced with adjacent ones to form plaques, leading to a deformity of the left ear (Fig. 1a) . smooth-walled, 0 -2 septate (predominantly 1-septate) conidia (Fig. 2d, e) . The fungal isolate hydrolyzed urea and was nitrate positive and grew on media containing cycloheximide. The fungus was identifi ed as Veronaea botryosa based on its morphological characteristics [1, 2] . The isolate has been deposited in the Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China under accession number CMCC(FD.28C).
Molecular testing
Genomic DNA was extracted using Biopsin Fungus Genomic DNA Extraction Kit(Bioer Technology, China) according to the manufacturer ' s protocol, The universal fungal primer pair was used for amplifi cation: ITS1(5 ′ -TCCGTAGGT GAACCTGCGG-3 ′ ) and ITS4(5 ′ -TCCTCCGCTTATTG ATATGC-3 ′ ). The PCR assay was performed using 0.5 μ l of the test DNA sample in a total reaction volume of 25 μ l. The PCR master mix consisted of 11 μ l of nuclease-free water, 0.5 μ l stock of each primer (10 μ M),12.5 μ l of 2 ϫ Go Taq Green Master mix (Promega Corporation).Thirtyfi ve cycles of amplifi cation were performed in a BioRad MyCycler thermocycler after initial denaturation of DNA at 95 ° C for 10 min. Each cycle consisted of a denaturation step at 94 ° C for 30 s, an annealing step at 55 ° C for 40 s, and an extension step at 72 ° C for 1 min, with a fi nal extension at 72 ° C for 7 min following the last cycle. Following amplification, an approximately 601-bp amplicon was detected.
DNA sequencing of the PCR product was done at the Shanghai Sangon Biological Engineering Technology Service Company on ABI PRISM 3730DNA sequencer using BigDye terminator v3.1 according to the manufacturer ' s protocols. The PCR product was directly sequenced using both the ITS1 primer and ITS4 primer. The resultant nucleotide sequences were aligned to produce consensus for analysis. The consensus sequence of the isolate aligned with 99% sequence similarity to multiple sequences of V. botryosa available in the GenBank database.
Drug sensitivity test
In vitro antifungal susceptibility testing was performed through the use of a macrobroth modifi cation of the previously published Standard M38-A from ' National Committee for Clinical Laboratory Standards ' reference method for broth dilution antifungal susceptibility testing of fi lamentous fungi [3] . In vitro minimal inhibitory concentrations (MICs) of several antifungals against V. botryosa were as follows; itraconazole (2 μ g/ml), fl uconazole ( Ͼ 64 μ g/ml), terbinafi ne (1 μ g/ml), ketaconazole (2 μ g/ml), miconazole ( Ͼ 4 μ g/ml), bifconazole ( Ͼ 4 μ g/ml), nystatin (4 μ g/ml), amphotericin B (1 μ g/ml).
The patient was a high-school student and had no active gardening, soil or water exposure. She had no history of immune diseases or infections and her family history was unremarkable. Physical examination revealed multiple, non-tender, erythematous, crusted nodules or plaques on the left ear and left buttock. Superfi cial lymph nodes were non-palpable. No abnormal fi ndings were noted in a blood test, urine test, chest X-rays, cranial CT and abdominal ultrasound. Skin biopsies from the lesions on the left ear and buttock were obtained and subjected to microscopic, histopathologic and fungal cultural examinations. The isolate recovered in culture was identifi ed as Veronaea botryosa according to the key characteristics described by Ellis [1] and de Hoog et al . [2] . Antifungal therapy was initiated with oral itraconazole 400 mg daily with adjuvant thermotherapy for 6 months. A signifi cant clinical improvement was noticed, however, a follow-up over a longer period of time was desired to assess the long-term outcome of the treatment. In a 2-year follow-up the lesions were resolved and there was no evidence of recurrence.
Histopathologic examination
Sections of the biopsy tissues collected from the left ear and left buttock were stained with haematoxylin and eosin (H&E), periodic acid Schiff ' s reagent (PAS), and Gomori methenamine silver (GMS) procedures. Microscopic examination of the H&E-stained tissue revealed a chronic granulomatous infl ammation infi ltrated with lymphocytes, histiocytes, neutrophils, and multinucleated giant cells. The epidermis was thickened, irregular, and showed pseudoepitheliomatous hyperplasia. Septate, branched or unbranched and pale brown hyphae of various lengths were observed in the tissue (Fig. 2a) . Examination of the PAS (Fig. 2b) and Gomori methenamine silver stains (Fig. 2c ) also demonstrated the presence of septate hyphae.
Mycological examination
Portions of skin biopsies from verrucous lesions were inoculated onto potato dextrose agar plates containing chloramphenicol and cycloheximide. The culture plates were incubated at 25 ° C and 37 ° C in the dark and examined every other day. After two weeks, numerous velvety, olivaceous gray colonies were visible on all plates at both at 25 ° C and 37 ° C, but appeared to grow more rapidly at 25 ° C. No growth was evident at 40 ° C. Bacterial and mycobacterial cultures were negative. Scrapings from crusts of the lesions were examined in KOH mounts revealing numerous septate, branched, yellowish to brownish hyphae, 2.5 -4.0 μ m in diameter. The conidiophores were erect, straight or fl exous, occasionally branched, rarely geniculate, smooth-walled, septate, pale brown, bearing cylindric, 
Treatment
The patient received treatment in Jinling Hospital, Nanjing, China, with oral itraconazole, 400 mg daily, with adjuvant thermotherapy for the lesions on the left ear and left buttock. The thermotherapy used a small electric pad for 1 h every day, with the temperature of the skin surface during the thermotherapy reaching as high as approximately 41 -42 ° C. Over a period of 1 month, the lesions were significantly reduced. Subsequently, following a 10-week course of itraconazole, 200 mg BID, the patient ' s skin lesions were further resolved in that crusted verrucous nodules and plaques faded away leaving only residual depigmentation macula (Fig. 1c, d ). In order to achieve a clinical and mycological eradication, we scheduled a follow-up treatment over 2 years. The patient was on the treatment for 1 year and the lesions were completely healed. Then, oral itraconazole dose had been maintained at a lower dose of 100 mg/d and continued for one more year. After 2 years, follow-up examination showed no evidence of recurrence of the infection and liver function tests were normal.
Discussion
More The patient, in the present case, had a unique history of injury from a cosmetic procedure. V. botryosa infection was preceded by piercing of the ear lobules which may have resulted, a few months later, in a severe skin lesion. It was speculated that V. botryosa had gained entrance through the use of inadequately sterilized tools in the ear piercing or probably more likely, from the environment. The wound created a disintegrated skin barrier which precipitated the infection. Since skin is an anatomical barrier from external environmental pathogens, the integrity of skin plays an important role in the body ' s defense. Therefore, damage of skin could predispose individuals to opportunistic fungal infection, as in the present case.
In the nine human V. botryosa infections reported in the literature, therapeutic regimes were quite variable, but it appears that itraconazole is the most effective oral antifungal for phaeohyphomycosis. In the present case, combined therapy of oral itraconazole and local thermotherapy proved to be highly effective. The addition of local thermotherapy could be recommended as a useful adjuvant of antifungal therapy for V . botryosa or other dematiaceous infections. In addition, the initial dose of itraconazole is critical, as a low dose could lead to resistance. The therapeutic strategy we applied has shown its benefi t in all cases of phaeohyphomycotic infections we have thus far encountered.
The ability of V . botryosa to grow at 35 ° C, albeit slowly, potentiates invasive disease, especially in immunocompromised patients [10, 13] .This fi rst report of phaeohyphomycosis following ear piercing should alert dermatologists and the public to the risk of fungal infection through piercing. The increasing popular and pervasive nature of body piercing raises more side effects or complications. Many areas of the body are used for piercing, among which ears are the most common. Most of the time, an earlobe piercing heals without any problems. Piercing other areas of the ear containing cartilage is more likely to become infected than earlobes. Infectious diseases can be inadvertently transmitted when instruments are inadequately sterilized or through other poor techniques. A variety of bacteria and viruses that may cause infections in piercing areas have been reported, including Staphylococcus aureus , Pseudomonas aeruginosa , Streptococcus , HBV, and HIV-1 [16] . Interestingly, in the present case, a piercing in the left earlobe caused the development of a severe crusted verrucous lesion around the wound which later spread to the left buttock. Phaeohyphomycosis has arisen as a new medical complication of piercing. Our case suggests that although rare, body piercing could contribute to human phaeohyphomycosis in certain This paper was fi rst published online on Early Online on 24 September 2010.
circumstances such as inadequate sterilization, as well as susceptible individuals. Therefore, piercing procedures need to be carefully evaluated and patients should be apprised and warned of the potential for opportunistic fungal infections.
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